AQP7 Antibody / Aquaporin 7 Antibody

AQP7 Antibody Overview

AQP7 Antibody reagents target aquaporin 7, an aquaglyceroporin that facilitates transport of glycerol and water across cell membranes. Unlike water-selective aquaporins, AQP7 plays a dual role in energy regulation and hydration. It is primarily expressed in adipose tissue, where it mediates glycerol efflux from adipocytes during lipolysis. By releasing glycerol into the bloodstream, AQP7 connects fat metabolism to systemic energy supply.

AQP7 is also found in kidney proximal tubules, pancreatic islets, testis, and skeletal muscle. This wide distribution points to additional functions in renal solute handling, endocrine physiology, and reproductive biology. Dysregulated AQP7 expression has been linked to obesity, insulin resistance, and type 2 diabetes. Because of its central role in energy balance, the AQP7 Antibody is a critical reagent for studying adipose biology and metabolic disorders. The Aquaporin 7 Antibody complements these efforts with validated reagents across multiple research applications.

Why Choose AQP7 Antibodies from NSJ Bioreagents?

NSJ Bioreagents provides AQP7 Antibodies validated for immunohistochemistry, western blotting, immunofluorescence, flow cytometry, and ELISA. Each AQP7 Antibody undergoes stringent validation to ensure specificity, reproducibility, and cross-platform performance.

By choosing AQP7 Antibodies from NSJ Bioreagents, researchers gain reagents optimized for clarity and reliability. Our antibodies provide strong detection in adipose tissues, reproducible results in protein lysates, and consistent performance across translational pipelines. Comprehensive datasheets, suggested controls, and optimized protocols support reproducibility across research environments.

Applications of AQP7 Antibodies

The AQP7 Antibody supports broad applications across metabolism, endocrinology, and translational medicine.

1) Adipose Tissue and Obesity Research

• AQP7 Antibodies detect glycerol channels in adipocytes.

• The AQP7 Antibody supports studies of fat mobilization and obesity development.

• Aquaporin 7 Antibody reagents validate biomarkers for adipose metabolism.

2) Diabetes and Insulin Resistance

• AQP7 Antibodies reveal connections between glycerol release and glucose regulation.

• The AQP7 Antibody supports studies of type 2 diabetes and metabolic syndrome.

• Aquaporin 7 Antibody reagents extend applications into translational endocrinology.

3) Kidney and Renal Physiology

• AQP7 Antibodies detect expression in proximal tubules.

• The AQP7 Antibody supports studies of renal glycerol and water handling.

• Aquaporin 7 Antibody reagents validate nephrology biomarkers.

4) Endocrine and Pancreatic Function

• AQP7 Antibodies highlight expression in pancreatic β-cells.

• The AQP7 Antibody supports studies of insulin secretion and glucose metabolism.

• Aquaporin 7 Antibody reagents extend applications to islet biology.

5) Reproductive Biology

• AQP7 Antibodies detect expression in testis and sperm.

• The AQP7 Antibody supports studies of fertility and male reproductive health.

• Aquaporin 7 Antibody reagents provide markers for gamete function.

6) Translational and Clinical Research

• AQP7 Antibodies are integrated into biomarker-driven metabolic studies.

• The AQP7 Antibody supports diagnostics for obesity and diabetes.

• Aquaporin 7 Antibody reagents ensure reproducibility across translational pipelines.

Why Are AQP7 Antibodies Important?

AQP7 is a crucial aquaglyceroporin linking adipose tissue metabolism to systemic energy balance. The AQP7 Antibody equips researchers with validated reagents for investigating obesity, diabetes, and endocrine physiology, while the Aquaporin 7 Antibody extends applications into translational research.

In adipose biology, AQP7 Antibodies highlight mechanisms of glycerol efflux and fat mobilization. In diabetes research, the AQP7 Antibody clarifies connections between lipid metabolism and insulin resistance. In renal biology, Aquaporin 7 Antibody reagents support studies of glycerol reabsorption and nephrology biomarkers.

Clinically, AQP7 is emerging as a biomarker for obesity, type 2 diabetes, and related metabolic disorders. Reliable AQP7 Antibodies ensure reproducibility, bridging fundamental discoveries with diagnostic and therapeutic outcomes.

Conclusion

AQP7 integrates water and glycerol transport with systemic energy regulation, making it essential for obesity, diabetes, and renal biology research. The AQP7 Antibody provides validated reagents for adipose tissue, pancreatic islets, kidney, and reproductive tissues, while the Aquaporin 7 Antibody expands these applications across translational pipelines. By ensuring specificity, reproducibility, and assay versatility, these antibodies remain indispensable for advancing metabolic research and improving outcomes in obesity and diabetes care.